title: Balancing the risks and benefits of long-term antiplatelet therapies for cardiovascular disease: clinical, research, and regulatory implications.
authors: Duke Clinical Research Institute, Durham, NC (J.A., M.T.R.).
authors: Joakim
authors: J
authors: Alfredsson
authors: Duke Clinical Research Institute, Durham, NC (J.A., M.T.R.).
authors: Matthew T
authors: MT
authors: Roe
mesh_terms: D017277:Drug Approval; D005260:Female; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D058729:Peripheral Arterial Disease / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D055502:Secondary Prevention / Q000379:methods*
chemical_list: D007783:Lactones; D010975:Platelet Aggregation Inhibitors; D011725:Pyridines
keywords: Editorials; arteriosclerosis; platelets; prevention; thrombin